Correlation Between Bristol-Myers Squibb and Bayer AG
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Bayer AG, you can compare the effects of market volatilities on Bristol-Myers Squibb and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Bayer AG.
Diversification Opportunities for Bristol-Myers Squibb and Bayer AG
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bristol-Myers and Bayer is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Bayer AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Bayer AG go up and down completely randomly.
Pair Corralation between Bristol-Myers Squibb and Bayer AG
Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 1.33 times more return on investment than Bayer AG. However, Bristol-Myers Squibb is 1.33 times more volatile than Bayer AG. It trades about 0.22 of its potential returns per unit of risk. Bayer AG is currently generating about -0.4 per unit of risk. If you would invest 84,453 in Bristol Myers Squibb on August 27, 2024 and sell it today you would earn a total of 16,102 from holding Bristol Myers Squibb or generate 19.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 90.48% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Bayer AG
Performance |
| Timeline |
| Bristol Myers Squibb |
| Bayer AG |
Bristol-Myers Squibb and Bayer AG Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol-Myers Squibb and Bayer AG
The main advantage of trading using opposite Bristol-Myers Squibb and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.| Bristol-Myers Squibb vs. Novartis AG | Bristol-Myers Squibb vs. Bayer AG | Bristol-Myers Squibb vs. Astellas Pharma | Bristol-Myers Squibb vs. Roche Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |